Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

Childhood brain tumors: current management, biological insights, and future directions.

Pollack IF, Agnihotri S, Broniscer A.

J Neurosurg Pediatr. 2019 Mar 1;23(3):261-273. doi: 10.3171/2018.10.PEDS18377. Review.

PMID:
30835699
2.

Multidisciplinary management of childhood brain tumors: a review of outcomes, recent advances, and challenges.

Pollack IF.

J Neurosurg Pediatr. 2011 Aug;8(2):135-48. doi: 10.3171/2011.5.PEDS1178. Review.

PMID:
21806354
3.

Prognostic effect of whole chromosomal aberration signatures in standard-risk, non-WNT/non-SHH medulloblastoma: a retrospective, molecular analysis of the HIT-SIOP PNET 4 trial.

Goschzik T, Schwalbe EC, Hicks D, Smith A, Zur Muehlen A, Figarella-Branger D, Doz F, Rutkowski S, Lannering B, Pietsch T, Clifford SC.

Lancet Oncol. 2018 Dec;19(12):1602-1616. doi: 10.1016/S1470-2045(18)30532-1. Epub 2018 Nov 1.

4.

Pediatric glial tumors.

Cohen KJ, Broniscer A, Glod J.

Curr Treat Options Oncol. 2001 Dec;2(6):529-36. Review.

PMID:
12057098
5.

Malignant brainstem tumors in children, excluding diffuse intrinsic pontine gliomas.

Klimo P Jr, Nesvick CL, Broniscer A, Orr BA, Choudhri AF.

J Neurosurg Pediatr. 2016 Jan;17(1):57-65. doi: 10.3171/2015.6.PEDS15166. Epub 2015 Oct 16.

PMID:
26474099
6.

Molecular insights into pediatric brain tumors have the potential to transform therapy.

Gajjar A, Pfister SM, Taylor MD, Gilbertson RJ.

Clin Cancer Res. 2014 Nov 15;20(22):5630-40. doi: 10.1158/1078-0432.CCR-14-0833. Review.

7.

Pseudoprogression in children, adolescents and young adults with non-brainstem high grade glioma and diffuse intrinsic pontine glioma.

Carceller F, Fowkes LA, Khabra K, Moreno L, Saran F, Burford A, Mackay A, Jones DT, Hovestadt V, Marshall LV, Vaidya S, Mandeville H, Jerome N, Bridges LR, Laxton R, Al-Sarraj S, Pfister SM, Leach MO, Pearson AD, Jones C, Koh DM, Zacharoulis S.

J Neurooncol. 2016 Aug;129(1):109-21. doi: 10.1007/s11060-016-2151-8. Epub 2016 May 14.

PMID:
27180091
8.

Cervicomedullary tumors in children.

McAbee JH, Modica J, Thompson CJ, Broniscer A, Orr B, Choudhri AF, Boop FA, Klimo P Jr.

J Neurosurg Pediatr. 2015 Oct;16(4):357-66. doi: 10.3171/2015.5.PEDS14638. Epub 2015 Jun 26.

PMID:
26114990
9.

Treatments for astrocytic tumors in children: current and emerging strategies.

Burzynski SR.

Paediatr Drugs. 2006;8(3):167-78. Review.

PMID:
16774296
10.

Current and future strategies in radiotherapy of childhood low-grade glioma of the brain. Part II: Treatment-related late toxicity.

Kortmann RD, Timmermann B, Taylor RE, Scarzello G, Plasswilm L, Paulsen F, Jeremic B, Gnekow AK, Dieckmann K, Kay S, Bamberg M.

Strahlenther Onkol. 2003 Sep;179(9):585-97. Review.

PMID:
14628124
11.
12.

A multi-disciplinary consensus statement concerning surgical approaches to low-grade, high-grade astrocytomas and diffuse intrinsic pontine gliomas in childhood (CPN Paris 2011) using the Delphi method.

Walker DA, Liu J, Kieran M, Jabado N, Picton S, Packer R, St Rose C; CPN Paris 2011 Conference Consensus Group.

Neuro Oncol. 2013 Apr;15(4):462-8. doi: 10.1093/neuonc/nos330. Epub 2013 Mar 15. Review.

13.

Surgical and molecular considerations in the treatment of pediatric thalamopeduncular tumors.

Lee RP, Foster KA, Lillard JC, Klimo P Jr, Ellison DW, Orr B, Boop FA.

J Neurosurg Pediatr. 2017 Sep;20(3):247-255. doi: 10.3171/2017.4.PEDS16668. Epub 2017 Jul 7.

14.

Proposed therapeutic strategy for adult low-grade glioma based on aggressive tumor resection.

Nitta M, Muragaki Y, Maruyama T, Ikuta S, Komori T, Maebayashi K, Iseki H, Tamura M, Saito T, Okamoto S, Chernov M, Hayashi M, Okada Y.

Neurosurg Focus. 2015 Jan;38(1):E7. doi: 10.3171/2014.10.FOCUS14651.

PMID:
25599276
15.

Current and future strategies in radiotherapy of childhood low-grade glioma of the brain. Part I: Treatment modalities of radiation therapy.

Kortmann RD, Timmermann B, Taylor RE, Scarzello G, Plasswilm L, Paulsen F, Jeremic B, Gnekow AK, Dieckmann K, Kay S, Bamberg M.

Strahlenther Onkol. 2003 Aug;179(8):509-20. Review.

PMID:
14509949
16.

Targeted next-generation sequencing of pediatric neuro-oncology patients improves diagnosis, identifies pathogenic germline mutations, and directs targeted therapy.

Kline CN, Joseph NM, Grenert JP, van Ziffle J, Talevich E, Onodera C, Aboian M, Cha S, Raleigh DR, Braunstein S, Torkildson J, Samuel D, Bloomer M, Campomanes AGA, Banerjee A, Butowski N, Raffel C, Tihan T, Bollen AW, Phillips JJ, Korn WM, Yeh I, Bastian BC, Gupta N, Mueller S, Perry A, Nicolaides T, Solomon DA.

Neuro Oncol. 2017 May 1;19(5):699-709. doi: 10.1093/neuonc/now254.

17.

Paediatric high and low grade glioma: the impact of tumour biology on current and future therapy.

Hargrave D.

Br J Neurosurg. 2009 Aug;23(4):351-63. doi: 10.1080/02688690903158809. Review.

PMID:
19637006
18.

Malignant Brain Tumours in Children : Present and Future Perspectives.

Rutka JT.

J Korean Neurosurg Soc. 2018 May;61(3):402-406. doi: 10.3340/jkns.2018.0044. Epub 2018 May 1. Review.

19.

Factors associated with progression-free survival and long-term neurological outcome after resection of intramedullary spinal cord tumors: analysis of 101 consecutive cases.

Garc├ęs-Ambrossi GL, McGirt MJ, Mehta VA, Sciubba DM, Witham TF, Bydon A, Wolinksy JP, Jallo GI, Gokaslan ZL.

J Neurosurg Spine. 2009 Nov;11(5):591-9. doi: 10.3171/2009.4.SPINE08159.

PMID:
19929363
20.

A pediatric trial of radiation/cetuximab followed by irinotecan/cetuximab in newly diagnosed diffuse pontine gliomas and high-grade astrocytomas: A Pediatric Oncology Experimental Therapeutics Investigators' Consortium study.

Macy ME, Kieran MW, Chi SN, Cohen KJ, MacDonald TJ, Smith AA, Etzl MM, Kuei MC, Donson AM, Gore L, DiRenzo J, Trippett TM, Ostrovnaya I, Narendran A, Foreman NK, Dunkel IJ.

Pediatr Blood Cancer. 2017 Nov;64(11). doi: 10.1002/pbc.26621. Epub 2017 May 24.

Supplemental Content

Support Center